• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Massive left atrial thrombus in a patient with rheumatic mitral stenosis and atrial fibrillation while anticoagulated with dabigatran.

作者信息

Luis Sushil Allen, Poon Karl, Luis Chris, Shukla Akhil, Bett Nicholas, Hamilton-Craig Christian

机构信息

Department of Cardiology, The Prince Charles Hospital, Brisbane, Queensland 4032, Australia.

出版信息

Circ Cardiovasc Imaging. 2013 May 1;6(3):491-2. doi: 10.1161/CIRCIMAGING.113.000253.

DOI:10.1161/CIRCIMAGING.113.000253
PMID:23696587
Abstract
摘要

相似文献

1
Massive left atrial thrombus in a patient with rheumatic mitral stenosis and atrial fibrillation while anticoagulated with dabigatran.一名风湿性二尖瓣狭窄合并心房颤动患者在使用达比加群抗凝治疗时出现巨大左心房血栓。
Circ Cardiovasc Imaging. 2013 May 1;6(3):491-2. doi: 10.1161/CIRCIMAGING.113.000253.
2
Dabigatran for stroke prevention in all patients with atrial fibrillation?达比加群用于所有房颤患者的卒中预防？
Pharmacotherapy. 2011 Aug;31(8):725-8. doi: 10.1592/phco.31.8.725.
3
Dabigatran compared with warfarin for stroke prevention in atrial fibrillation.达比加群与华法林在心房颤动卒中预防中的比较。
Ann Intern Med. 2011 Apr 19;154(8):570; author reply 570-1. doi: 10.7326/0003-4819-154-8-201104190-00013.
4
Endovascular thrombectomy for acute ischemic stroke patients anticoagulated with dabigatran.达比加群抗凝的急性缺血性卒中患者的血管内血栓切除术
Clin Neurol Neurosurg. 2013 Oct;115(10):2257-9. doi: 10.1016/j.clineuro.2013.07.017. Epub 2013 Aug 3.
5
Dabigatran and atrial fibrillation: the alternative to warfarin for selected patients.达比加群与心房颤动：特定患者使用的华法林替代药物
Prescrire Int. 2012 Feb;21(124):33-6.
6
Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation.达比加群酯预防房颤卒中的成本效果分析。
Circulation. 2011 Jun 7;123(22):2562-70. doi: 10.1161/CIRCULATIONAHA.110.985655. Epub 2011 May 23.
7
Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion.达比加群酯与华法林在心房颤动患者中的比较：一项关于接受心脏转复术患者的分析。
Circulation. 2011 Jan 18;123(2):131-6. doi: 10.1161/CIRCULATIONAHA.110.977546. Epub 2011 Jan 3.
8
Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial.RE-LY 试验中接受达比加群或华法林治疗的心房颤动患者的心肌缺血事件。
Circulation. 2012 Feb 7;125(5):669-76. doi: 10.1161/CIRCULATIONAHA.111.055970. Epub 2012 Jan 3.
9
Stroke prophylaxis with warfarin or dabigatran for patients with non-valvular atrial fibrillation-cost analysis.非瓣膜性心房颤动患者的华法林或达比加群预防中风的成本分析。
Age Ageing. 2012 Sep;41(5):681-4. doi: 10.1093/ageing/afs017. Epub 2012 Feb 28.
10
An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.达比加群、利伐沙班和阿哌沙班治疗心房颤动的间接比较。
Thromb Haemost. 2012 Sep;108(3):476-84. doi: 10.1160/TH12-02-0093. Epub 2012 Jun 28.

引用本文的文献

1
Prevalence and predictors of left atrial thrombus in patients with rheumatic atrial fibrillation undergoing cardiac surgery: a cross-sectional study.心脏手术中风湿性心房颤动患者左心房血栓的患病率及预测因素：一项横断面研究
BMC Cardiovasc Disord. 2025 Jan 13;25(1):19. doi: 10.1186/s12872-025-04473-6.
2
Large Left Atrial Thrombus in a Patient With Severe Mitral Stenosis and Atrial Fibrillation Despite Anticoagulant Therapy: A Case Report.尽管接受了抗凝治疗，但严重二尖瓣狭窄和心房颤动患者仍出现巨大左心房血栓：一例报告
Cureus. 2024 Jan 20;16(1):e52634. doi: 10.7759/cureus.52634. eCollection 2024 Jan.
3
Giant Left Atrial Thrombus Despite Anticoagulation with Apixaban in a Patient with Mitral Stenosis and Atrial Fibrillation.
尽管在合并二尖瓣狭窄和心房颤动的患者中使用阿哌沙班进行抗凝治疗，但仍存在巨大左心房血栓。
Am J Case Rep. 2021 Sep 25;22:e933162. doi: 10.12659/AJCR.933162.
4
Left atrial appendage thrombus on full-dose dabigatran treatment: a case report.全剂量达比加群治疗期间出现左心耳血栓：一例报告
Eur Heart J Case Rep. 2020 Apr 24;4(3):1-4. doi: 10.1093/ehjcr/ytaa057. eCollection 2020 Jun.
5
Successful thrombolysis for acute ischaemic stroke after reversal of dabigatran etexilate with idarucizumab.达比加群酯用艾达司珠单抗逆转后急性缺血性卒中成功溶栓治疗。
BMJ Case Rep. 2019 May 5;12(5):e229128. doi: 10.1136/bcr-2018-229128.
6
Left Atrial Appendage Thrombus Formation in a Patient on Dabigatran Therapy Associated With and Genetic Defect.达比加群治疗患者发生左心耳血栓形成与遗传缺陷相关
Front Pharmacol. 2018 May 15;9:491. doi: 10.3389/fphar.2018.00491. eCollection 2018.
7
Safety and Efficacy of Novel Oral Anticoagulants Versus Warfarin in Medicare Beneficiaries With Atrial Fibrillation and Valvular Heart Disease.新型口服抗凝剂与华法林在 Medicare 福利受益人群伴心房颤动和心脏瓣膜病中的安全性和疗效。
J Am Heart Assoc. 2018 Apr 5;7(8):e008773. doi: 10.1161/JAHA.118.008773.
8
Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants.非维生素K口服抗凝剂时代的证据空白
J Am Heart Assoc. 2018 Jan 26;7(3):e007338. doi: 10.1161/JAHA.117.007338.
9
Effects of novel oral anticoagulants on left atrial and left atrial appendage thrombi: an appraisal.新型口服抗凝剂对左心房及左心耳血栓的影响：一项评估
J Thromb Thrombolysis. 2017 Feb;43(2):139-148. doi: 10.1007/s11239-016-1421-9.
10
Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions.直接口服抗凝剂在心房颤动合并心脏瓣膜病变患者中的应用。
J Am Heart Assoc. 2016 Feb 18;5(2):e002776. doi: 10.1161/JAHA.115.002776.